Influenza Vaccine in Pregnancy May Reduce Fetal Deaths Girls who receive the quadrivalent human papillomavirus (HPV) vaccine before 17 years of age can get considerable protection from condyloma after ...
In men, human papillomavirus (HPV) infection can cause two different types of external genital lesions: condylomata (genital warts) and penile intraepithelial neoplasia (PeIN). A new study provides ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jzd89v/genital_warts) has announced the addition of the "Genital Warts ...
The study selection process is presented in Figure 1. The literature search retrieved 616 references. In addition, we received 12 references from the pharmaceutical companies with marketing ...
DUBLIN--(BUSINESS WIRE)--The "Genital Warts (Condylomata Acuminata) Ongoing Global Clinical Trials Analysis and Outlook" report has been added to ResearchAndMarkets.com's offering. Genital Warts ...
New research presented today at the EADV 30 th Congress reveals a link between genital warts and the human leukocyte antigen (HLA) system - the part of the immune system which helps regulate immune ...
Genital warts are a sexually transmitted disease that is caused by the human papillomavirus (HPV). There are various treatment and preventative options available for genital warts. External genital ...
Condylomata acuminata, also known as genital warts, manifest with a variety of appearances. They may be flesh- colored, brown, or purple papules, plaques, or nodules on the skin or mucous membranes of ...
Background: Anal condylomata acuminata are caused by human papilloma virus (HPV) infection which is transmitted by close physical and sexual contact. The result of surgical treatment of ACA has an ...
New research presented today at the EADV 30th Congress reveals a link between genital warts and the human leukocyte antigen (HLA) system—the part of the immune system which helps regulate immune ...
We included randomised clinical trials (RCT) that examined the efficacy of a HPV catch-up vaccination of young women aged 16 and older. Eligible RCTs examined the effect of HPV vaccines on overall ...